Integrated Metabolic and Inflammatory Clustering Reveals Distinct Risk Profiles for Digestive Diseases
Advanced Science · 2025-11 · 12 (44)
DOI: 10.1002/advs.202511000 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 28.09.2025. Verfasst von Zhenhe Jin und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310003, China. Hauptthemen laut MEDLINE: Digestive System Diseases, Inflammation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, High-Level Talent Science and Technology Innovation Leading Talent Program of Zhejiang Province, Science and Technology Program of Zhejiang Province.
Abstract (Originalsprache)
Emerging research highlights the complex relationship between metabolic dysfunction and chronic low‐grade inflammation, which disrupts gut homeostasis and drives disease progression. However, most current studies evaluate metabolic and inflammatory markers separately, relying on basic indicators such as body mass index (BMI) or individual biomarkers. In this study, a scalable clustering framework is developed to integrate six clinical parameters in 398 432 participants from the UK Biobank, identifying four distinct metabolic‐inflammatory subtypes. Cox proportional hazards models demonstrate significant associations between these subtypes and digestive disease risk. Using 251 plasma metabolites and elastic net regression, cluster‐associated metabolite signatures are identified. Mediation analyses indicate that metabolic signatures mediate the association between clusters and digestive disease risk. Machine learning algorithms are applied to construct disease‐specific metabolic risk scores, achieving C‐indices above 0.70 for ten digestive disease endpoints. Explainable machine learning approaches further identify both shared and disease‐specific predictors, with glycoprotein acetyls, valine, tyrosine, and fatty acids emerging as key risk indicators. This integrative approach provides a comprehensive framework for digestive disease risk assessment and offers novel insights into the metabolic mechanisms underlying disease susceptibility.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310003, China.
- Department of Gastroenterology, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, Zhejiang, 321000, China.
ORCID-Profile: Zhe Shen
Förderung
- National Natural Science Foundation of China
- High-Level Talent Science and Technology Innovation Leading Talent Program of Zhejiang Province
- Science and Technology Program of Zhejiang Province
Zitieren
APA
Jin, Z., Chen, Q., Zhou, L., Ye, K., Liu, Z., Jiang, W., Luo, L., Wang, Y., Ye, X., Yu, C., & Shen, Z. (2025). Integrated Metabolic and Inflammatory Clustering Reveals Distinct Risk Profiles for Digestive Diseases. Advanced Science, 12(44). https://doi.org/10.1002/advs.202511000
Vancouver
Jin Z, Chen Q, Zhou L, Ye K, Liu Z, Jiang W, et al. Integrated Metabolic and Inflammatory Clustering Reveals Distinct Risk Profiles for Digestive Diseases. Advanced Science. 2025;12(44). doi:10.1002/advs.202511000
BibTeX
@article{Jin2025,
author = {Jin, Zhenhe and Chen, Qichen and Zhou, Liangfeng and Ye, Kexin and Liu, Zhaoxue and Jiang, Wenxi and Luo, Linwen and Wang, Yize and Ye, Xiaohua and Yu, Chaohui and Shen, Zhe},
title = {Integrated Metabolic and Inflammatory Clustering Reveals Distinct Risk Profiles for Digestive Diseases},
journal = {Advanced Science},
year = {2025},
volume = {12},
number = {44},
doi = {10.1002/advs.202511000}
}
EUVIMED